Clinical Trial Update: NYU Ovarian Cancer Early Detection Program Blood and Genetics

View source ↗

Summary

The NYU ovarian cancer early detection program blood and genetics clinical trial has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: NYU Langone Health | Conditions: Ovarian Cancer | Status: TERMINATED